Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Healthy Extracts (HYEX) Loans and Notes Receivables (2016 - 2018)

Healthy Extracts filings provide 3 years of Loans and Notes Receivables readings, the most recent being $79295.0 for Q3 2018.

  • On a quarterly basis, Loans and Notes Receivables changed 0.0% to $79295.0 in Q3 2018 year-over-year; TTM through Sep 2018 was $79295.0, a 0.0% change, with the full-year FY2017 number at $79295.0, up 71.28% from a year prior.
  • Loans and Notes Receivables hit $79295.0 in Q3 2018 for Healthy Extracts, roughly flat from $79295.0 in the prior quarter.
  • In the past five years, Loans and Notes Receivables ranged from a high of $79295.0 in Q2 2017 to a low of $46295.0 in Q4 2016.
  • Median Loans and Notes Receivables over the past 3 years was $79295.0 (2017), compared with a mean of $73545.0.
  • Biggest five-year swings in Loans and Notes Receivables: surged 71.28% in 2017 and later changed 0.0% in 2018.
  • Healthy Extracts' Loans and Notes Receivables stood at $46295.0 in 2016, then surged by 71.28% to $79295.0 in 2017, then changed by 0.0% to $79295.0 in 2018.
  • The last three reported values for Loans and Notes Receivables were $79295.0 (Q3 2018), $79295.0 (Q2 2018), and $79295.0 (Q1 2018) per Business Quant data.